Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008
Elevation of serum tumor markers in patients with interstitial lung disease Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011
Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 362s Year: 2003
Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Serum and bronchial aspiration fluid HE-4 levels in lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015
Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011
Comparative evaluation of the diagnostic value of serum tumor markers versus those identified in bronchial lavage fluid in patients with histologically confirmed bronchial carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Epithelial overexpression of interleukin-8 in bronchial biopsies from patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 673s Year: 2006
Decrease of skin reactivity to histamine in lung cancer patients Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours Year: 2009
Serum angiopoietins as a clinical marker for resected early lung cancer Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Potential diagnostic markers in bronquial fluid of patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006
Retinoid Receptors levels in normal bronchial mucosa and in lung cancer cell lines Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Apoptosis of circulating and BALF lymphocytes of patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004
Bacterial features of bronchial washing in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 355s Year: 2002
Expression of MAGE in the induced sputum of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 595s Year: 2002